Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TOB-STOP-COP: High vs Low Intensity Smoking Cessation in COPD
NCT04088942Phase 4Withdrawn
- Start
- Jul 2023
- Primary completion
- Jan 2026
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial (2 arms). Primary endpoint: Anamnestic and biochemical validated smoking cessation at 12 months. Planned start Jul 2023; status: withdrawn.
Beyond the preview
Go deeper on NCT04088942.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04088942.